Posted by on January 28, 2021 1:46 pm
Originally From: TowleRoad

Tags: , , ,

The FDA this week approved the use of once-a-month injectable Cabenuva for people living with HIV.

The FDA reports: “The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine. This is the first FDA-approved injectable, complete regimen for HIV-infected adults that is administered once a month.”

Said John Farley, M.D., M.P.H., director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research: “Currently, the standard of care

READ MORE OF THIS POST AT TowleRoad

Leave a Reply

Your email address will not be published. Required fields are marked *

Live Guys Online Now!
Live Guys Online Now!